GlassScriptPhysician profile
Saro Kasparian
NPI 1104350917
$15,377.33
in general payments reported to CMS, 2019-2025
69 companies · $6,164 in 2025
The $6,164 reported for 2025 was more than what 84% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $529 · 2022: $278 · 2023: $2,076 · 2024: $6,330 · 2025: $6,164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Education: $666.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,903.84 |
| Education | $666.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,289.48 | 2021-2025 | Enhertu, Tagrisso, Imfinzi |
| Janssen Biotech, INC. | $974.46 | 2023-2025 | Rybrevant, Erleada, Carvykti |
| Incyte Corporation | $852.71 | 2022-2025 | Jakafi, Monjuvi, Niktimvo |
| Merck Sharp & Dohme LLC | $779.08 | 2023-2025 | Keytruda, Welireg, Lynparza |
| Celgene Corporation | $727.04 | 2023-2025 | Reblozyl, Opdivo |
| Pfizer INC. | $630.69 | 2023-2025 | |
| Astellas Pharma US INC | $582.51 | 2023-2025 | Xospata, Xtandi, Vyloy |
| Seagen INC. | $570.21 | 2021-2025 | Padcev, Tukysa, Adcetris |
| E.R. Squibb & Sons, L.L.C. | $539.49 | 2023-2025 | Opdivo, Opdualag, Orencia |
| Eisai INC. | $435.35 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $427.11 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $423.38 | 2023-2025 | Iclusig, Fruzaqla, Ninlaro |
| Genzyme Corporation | $418.09 | 2023-2025 | |
| Genentech USA, INC. | $379.80 | 2023-2025 | Phesgo, Venclexta, Itovebi |
| Gilead Sciences, INC. | $379.54 | 2022-2025 | Trodelvy |
Show all 69 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exelixis INC. | $364.70 | 2023-2025 | Cabometyx |
| Lilly USA, LLC | $335.37 | 2023-2025 | Verzenio, Jaypirca, Retevmo |
| Tersera Therapeutics LLC | $298.27 | 2024-2025 | Zoladex, Xermelo |
| Pharmaessentia USA Corporation | $291.01 | 2023-2025 | Besremi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $282.97 | 2023-2025 | Gilotrif |
| Bayer Healthcare Pharmaceuticals INC. | $280.18 | 2023-2025 | |
| Abbvie INC. | $247.20 | 2024-2025 | |
| Array Biopharma INC | $239.47 | 2023-2025 | Braftovi, Mektovi, Lorbrena |
| Karyopharm Therapeutics INC. | $230.02 | 2023-2025 | Xpovio |
| Adc Therapeutics America, INC. | $170.64 | 2024-2025 | |
| Glaxosmithkline, LLC. | $168.97 | 2024-2025 | Ojjaara, Jemperli, Zejula |
| Sobi, INC | $161.41 | 2024-2025 | |
| Emd Serono, INC. | $160.56 | 2023-2025 | Bavencio |
| Genmab U.S., INC. | $158.84 | 2023-2025 | Epkinly |
| Deciphera Pharmaceuticals INC. | $158.03 | 2023-2025 | Qinlock, Romvimza |
| Kite Pharma, INC. | $151.83 | 2024-2025 | Yescarta |
| Janssen Scientific Affairs, LLC | $144.81 | 2023 | Erleada |
| Daiichi Sankyo INC. | $139.70 | 2024-2025 | Enhertu |
| Geron Corporation | $121.93 | 2025 | Rytelo |
| Blueprint Medicines Corporation | $117.95 | 2023-2025 | Ayvakit |
| Taiho Oncology, INC. | $116.53 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $92.99 | 2025 | |
| Beigene USA, INC. | $89.43 | 2023 | Brukinsa |
| Beone Medicines USA, INC. | $84.84 | 2025 | Tevimbra, Brukinsa |
| Alexion Pharmaceuticals, INC. | $82.49 | 2024-2025 | Ultomiris |
| Pulmonx Corporation | $79.38 | 2024 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Caris Mpi, INC. | $78.98 | 2025 | Mi Cancer Seek |
| Puma Biotechnology, INC. | $78.35 | 2023-2024 | |
| Legend Biotech USA INC. | $72.21 | 2025 | Carvykti |
| Stemline Therapeutics INC. | $66.01 | 2025 | Orserdu |
| Mirati Therapeutics, INC. | $65.45 | 2023-2024 | Krazati |
| Amgen INC. | $61.92 | 2023-2025 | Imdelltra (Amg757), Lumakras |
| Dendreon Pharmaceuticals LLC | $59.65 | 2025 | Provenge |
| Agios Pharmaceuticals, INC. | $59.46 | 2025 | Pyrukynd |
| Sun Pharmaceutical Industries INC. | $54.40 | 2024 | |
| Servier Pharmaceuticals LLC | $49.52 | 2023-2025 | |
| Immunogen, INC. | $45.22 | 2023-2024 | Elahere, Elahere |
| Jazz Pharmaceuticals INC. | $44.39 | 2024 | |
| Coherus Oncology, INC. | $43.85 | 2024-2025 | Loqtorzi |
| Tempus Ai, INC | $40.72 | 2024-2025 | Xt Cdx |
| Regeneron Healthcare Solutions, INC. | $37.71 | 2025 | Lynozyfic |
| Immunocore Limited | $34.25 | 2024 | Kimmtrak |
| Acrotech Biopharma INC. | $31.16 | 2025 | Beleodaq |
| Springworks Therapeutics, INC. | $29.86 | 2024 | Ogsiveo |
| Pharmacosmos Therapeutics INC. | $28.92 | 2024 | Monoferric |
| Syndax Pharmaceuticals, INC. | $28.53 | 2025 | |
| Organon LLC | $27.82 | 2024 | |
| Progenics Pharmaceuticals, INC. | $26.78 | 2025 | |
| Sumitomo Pharma America, INC. | $26.42 | 2023 | Orgovyx |
| Adaptive Biotechnologies Corporation | $26.00 | 2024 | Clonoseq |
| Ipsen Biopharmaceuticals, INC | $22.90 | 2025 | Onivyde, Somatuline Depot |
| Aveo Pharmaceuticals, INC. | $21.37 | 2023 | Fotivda |
| Chiesi USA, INC. | $18.57 | 2024 | Ferriprox |
| Azurity Pharmaceuticals, INC. | $18.45 | 2025 | Danziten |
Drugs and devices associated with these payments
Keytruda $753Reblozyl $701Jakafi $485Enhertu $468Erleada $456Lenvima $435Sarclisa $368Cabometyx $365Rybrevant $355Carvykti $352Verzenio $314Jaypirca $312Besremi $291Opdivo $270Tagrisso $268Welireg $241Braftovi $239Zoladex $231Elahere $231Xpovio $230Kisqali $221Nubeqa $218Mektovi $216Elrexfio $208Lynparza $207Adcetris $206Tivdak $205Tukysa $191Venclexta $178Gilotrif $177Xtandi $173Akeega $168Balversa $168Phesgo $161Iclusig $161Tecvayli $159Epkinly $159Qinlock $158Xospata $155Darzalex $155Yescarta $152Ayvakit $144Fruzaqla $132Scemblix $131Bosulif $130Opdualag $129Lorbrena $126Ojjaara $123Rytelo $122Imfinzi $117Lonsurf $117Inqovi $117Stivarga $116Monjuvi $114Brukinsa $114Calquence $111Doptelet $110Retevmo $106Xalkori $93.20Keytruda Qlex $92.41Trodelvy $90.10Niktimvo $87.88Itovebi $85.89Ultomiris $82.49Vyloy $82.30Zephyr Endobronchial Valve $79.38Chartis Catheter $79.38Zephyr Delivery Catheter $79.38Pulmonx Chartis Tablet Console $79.38Ninlaro $79.18Mi Cancer Seek $78.98Mekinist $74.78Zynlonta $73.86Ibrance $72.64Talvey $69.53Xermelo $66.99Talzenna $66.31Orserdu $66.01Padcev $65.46Krazati $65.45Tevimbra $60.50Wayrilz $60.10Provenge $59.65Pyrukynd $59.46Orgovyx $59.08Zynyz $57.94Tecentriq Hybreza $57.88Tecentriq $57.88Pemazyre $56.31Odomzo $54.40Yonsa $54.40Vitrakvi $54.03Polivy $52.00Vonjo $51.43Tibsovo $49.52Romvimza $48.16Inlyta $47.97Jemperli $46.22Besponsa $46.16Imdelltra (Amg757) $45.76
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saro Kasparian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.